Seung-Yeon Kim

Part of GemVax & KAEL Co., Ltd., Gemvax AS is a Norwegian peptide-based drug development company that focuses on researching and developing treatments for Alzheimer's disease and prostate hyperplasia. The company is based in Porsgrunn, Norway. The company also develops and sell products such as CA filters and provide investment information. The company was founded by Mona Elisabeth Møller. Gemvax was acquired by VaxOnco, Inc. from Pharmexa A/S on October 30, 2008.

NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden.

Gem & Co. /KR/ engages in the provision of financial consulting and trading services. The company was founded on September 9, 2004 and is headquartered in Seongnam, South Korea.

Part of GemVax & KAEL Co., Ltd., KAEL-GemVax Co., Ltd. manufactures bio-pharmaceutical products. The company is based in Seongnam, South Korea. The CEOs of the South Korean company are Gyeong Hee Kim, Sang-Jae Kim, Magnus Moliteus.

Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea.